Nocardia rubra cell-wall skeleton activates an immune response in cervical tissue via stimulating FPR3 to enhance dendritic cell-mediated Th1 differentiation. 2023

Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, China.

Nocardia rubra cell wall skeleton (Nr-CWS) has proven to be a successful medicine for therapy of cervical human papillomavirus infection. The mechanism of action of Nr-CWS is unclear but may involve a stimulatory effect on the host immune system. We previously found that CD4+ T cells were increased in cervical tissue after Nr-CWS treatment. Microarray data from these cervical tissues revealed the significant upregulation of formylated peptide receptor 3 (FPR3). This study aimed to explore the role of Nr-CWS in immunomodulatory based on these findings. Examination of CD4+ T cell subsets in cervical tissue from patients who received Nr-CWS revealed substantial increases in Th1 cytokines and transcription factors. The regulatory effects of Nr-CWS on the function and phenotype of dendritic cells (DCs) were assessed in comparison with the traditional DC maturation inducer lipopolysaccharide (LPS). Similar to LPS, Nr-CWS potently induced DC maturation and interleukin-12 (IL-12) secretion. Differentiation of T cells induced by Nr-CWS stimulated DCs was assessed using the mixed lymphocyte reaction assay. Significant differentiation towards Th1 was evident. Finally, FPR3 expression in DCs in response to Nr-CWS and LPS was measured. Nr-CWS potently upregulated FPR3 expression, while the LPS did not. Silencing FPR3 in DCs reduced Nr-CWS-induced IL-12 production and Th1 cell polarization in co-cultured T cells. The collective findings indicate that Nr-CWS may target FPR3 on the surface of DC cells and activate a Th1-type immune response. The findings clarify the basis of the antiviral immune effects of Nr-CWS on human papillomavirus.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002584 Cervix Uteri The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal. Cervical Canal of the Uterus,Cervical Canal, Uterine,Ectocervix,Endocervical Canal,Endocervix,External Os Cervix,External Os of the Cervix,Uterine Cervical Canal,Cervix,Cervixes,Uterine Cervix,Canal, Endocervical,Canal, Uterine Cervical,Cervix, External Os,Cervix, Uterine,Endocervical Canals,Uterine Cervical Canals
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017358 Cell Wall Skeleton A mucoprotein found in the cell wall of various types of bacteria. It has adjuvant and antitumor activities and has been used to augment the production of lymphokine-activated killer (LAK) cells.
D018000 Receptors, Peptide Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behavior of cells. Peptide Hormone Receptors,Peptide Receptors,Peptide Hormone Receptor,Peptide Receptor,Receptors, Peptide Hormones,Receptors, Peptides,Hormone Receptor, Peptide,Hormone Receptors, Peptide,Hormones Receptors, Peptide,Peptide Hormones Receptors,Peptides Receptors,Receptor, Peptide,Receptor, Peptide Hormone,Receptors, Peptide Hormone
D018417 Th1 Cells A subset of helper-inducer T-lymphocytes which synthesize and secrete INTERLEUKIN-2; INTERFERON-GAMMA; and INTERLEUKIN-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions. T Helper 1 Cells,TH-1 Cells,Type 1 Helper T Cells,Cell, TH-1,Cell, Th1,Cells, TH-1,Cells, Th1,TH 1 Cells,TH-1 Cell,Th1 Cell

Related Publications

Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
August 2017, International journal of biological macromolecules,
Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
December 2022, Materials today. Bio,
Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
June 1982, Gan,
Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
January 1981, Cancer treatment reports,
Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
April 1986, Infection and immunity,
Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
January 2022, Pathology oncology research : POR,
Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
December 1986, Arzneimittel-Forschung,
Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
March 2022, Cancer medicine,
Qianyu Guo, and Wei Chen, and Junyi Sun, and Chunfang Zhao, and Xue Bai, and Yanan Zhang, and Ke Liu, and Lei Zhang, and Suxia Shao
February 1981, Cancer research,
Copied contents to your clipboard!